The final, formatted version of the article will be published soon.
SYSTEMATIC REVIEW article
Front. Nutr.
Sec. Nutrition and Microbes
Volume 11 - 2024 |
doi: 10.3389/fnut.2024.1470185
This article is part of the Research Topic Probiotics for Global Health: Advances, Applications and Challenges View all 13 articles
The Effect of Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis
Provisionally accepted- First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China
The incidence of NAFLD is increasing. Preclinical evidences indicate that modulation of the gut microbiome could be a promising target in nonalcoholic fatty liver disease.Method: A systematic review and network meta-analysis was conducted to compare the effect of probiotics, synbiotics, prebiotics, fecal microbiota transplant, and antibiotics on the liver-enzyme, metabolic effects and liver-specific in patients with NAFLD. The randomized controlled trails (RCTs), limited to English language were searched from database such as Pubmed, Embase, Web of science and Cochrane Library from inception to November 2024. Review Manager 5.3 was used to to draw a Cochrane bias risk. Inconsistency test and publication-bias were assessed by Stata 14.0. Random effect model was used to assemble direct and indirect evidences. The effects of the intervention were presented as mean differences with 95% confidence interval.Results: A total of 1921 patients from 37 RCTs were eventually included in our study. 23 RCTs evaluated probiotics, 10 RCTs evaluated synbiotics, 4 RCTs evaluated prebiotics, 3 RCTs evaluated FMT and one RCT evaluated antibiotics. Probiotics and synbiotics were associated with a significantly reduction in alanine aminotransferase [ALT, (MD: -5.09;95%CI: -9.79, -0.39), (MD: -7.38,95CI%: -11.94.-2.82) and liver stiffness measurement by elastograph [LSM, (MD: -0.37;95%CI: -0.49, -0.25), (MD: -1.00;95%CI: -1.59,-0.41)]. In addition to, synbiotics was superior to probiotics in reducing LSM. Synbiotics was associated with a significant reduction of Controlled Attenuation Parameter [CAP,]. Both probiotics and synbiotics were associated with a significant reduction of aspartate transaminase [AST, (MD: -7.81;95%CI: -15.49, -0.12), (MD: -13.32;95%CI: -23, -3.64)]. Probiotics and Allogenic FMT was associated with a significant reduction of Homeostatic Model Assessment for Insulin Resistance [HOMA-IR, (MD: -0.7,95%CI: -1.26, -0.15), (MD: -1.8,95%CI: -3.53, -0.07)]. Probiotics was associated with a significant reduction of body mass index [BMI,.The supplement of synbiotics and probiotics maybe a promising way to improve liverenzyme, LSM, and steatosis in patients with NAFLD. More randomized controlled trials are needed to determine the efficacy of FMT and antibiotics on NAFLD. And the incidence of adverse events of MTTs should be further explored.
Keywords: Non-alcoholic fatty liver disease, microbiome-targeted therapies, network metaanalysis, Fecal microbiota transplant, antibiotics, Probiotics, Synbiotics, Prebiotics
Received: 25 Jul 2024; Accepted: 11 Dec 2024.
Copyright: © 2024 Song, Qin, Zhang, liu, Zhao and Minghao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Liu Minghao, First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.